Formosa Laboratories, Inc. (TPE:4746)

Taiwan · Delayed Price · Currency is TWD

48.95

+1.25 (2.62%)

Sep 30, 2026, 1:30 PM CST

Market Cap	5.74B -25.8%
Revenue (ttm)	4.64B -2.7%
Net Income	475.70M
EPS	3.92
Shares Out	120.26M
PE Ratio	12.18
Forward PE	n/a
Dividend	3.00 (6.13%)
Ex-Dividend Date	Aug 24, 2026

Volume	1,017,830
Open	48.00
Previous Close	47.70
Day's Range	47.60 - 49.00
52-Week Range	45.00 - 68.70
Beta	0.47
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 11, 2026

About Formosa Laboratories

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, a... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1985

Employees 280

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 4746

Full Company Profile

Financial Performance

In 2025, Formosa Laboratories's revenue was 4.85 billion, an increase of 2.54% compared to the previous year's 4.73 billion. Earnings were 441.11 million, an increase of 180.48%.

Financial Statements